SCARSDALE, N.Y., March 30 /PRNewswire/ -- Double Helix Consulting US, a division of London-based Double Helix Development group, today announced the appointment of Ann Stuchiner to the position of Vice President. Stuchiner joins a multidisciplinary team of highly experienced strategic pricing, reimbursement and market access consultants with extensive experience across the healthcare industry, which provide product commercialization services to firms in the pharmaceutical, biotechnology and medical device industries. DHC US provides services spanning the product lifecycle, including the following:
Drew Baker, President of Double Helix Consulting US, commented, "Ann complements our international market access, pricing and reimbursement capabilities through her vast experience in planning and implementing product development and launch strategies for the US market. Ann Stuchiner has led product planning initiatives in myriad therapeutic areas and has particular expertise in oncology, neurosciences, infectious disease, cardiometabolics, gastroenterology and pain. Her intimate knowledge of managed care market structure, formulary management, contracting strategies, and marketing communications strengthens Double Helix's ability to meet our clients' commercial objectives in the increasingly cost-conscious and value-driven US market."
Chief Executive Officer of Double Helix Development Group, Dr. Wayne Phillips, added, "Double Helix Consulting offers a premier set of services to assist our clients in optimizing product commercialization by enhancing market access through a truly global team of professionals with deep experience from both the client and consulting sides. As an example, our growing emerging markets practice provides clients with the intelligence to implement successful strategies in the world's largest and most rapidly developing economies. Ann's experience in product planning and launch strategy bolsters our expanding capabilities."
Stuchiner founded and led the Managed Markets Group at FCB HealthCare. Prior to FCB, her consulting career focused on development and implementation of managed market access strategy to support commercial development and product launches on behalf of major biopharmaceutical and device firms. She was also Director of MC(2), the managed care division of Lowe McAdams. Prior to her work in medical product commercialization strategy, Ann was a healthcare benefit design consultant for major employers and managed care organizations. She has served as an advisor to both the US Senate Subcommittee on Labor and Healthcare Issues and the New York State Department of Insurance. She is a graduate of
|SOURCE Double Helix Consulting US|
Copyright©2009 PR Newswire.
All rights reserved